glp-1 colorectal cancer death risk study november 2025 Dr. Rhonda Patrick on X: "Ozempic may reduce the mortality from colon cancer. Colon patients taking drugs (Ozempic, Wegovy, Mounjaro) were less than half as likely to die within GLP‐1 receptor agonists and the

Human clinical trials are limited, and BPC-157 has not completed the rigorous FDA approval process required to be marketed as a drug for human use

To learn more about BPC-157 therapy and whether it might benefit your healing journey, contact Yoo Direct Health to schedule a consultation

Statements have not been evaluated by the FDA or any regulatory authority

Several studies have shown that a small percentage of people using GLP-1 receptor agonists experience headaches, but even these results are unclear

"There's a lot of overlap between the symptoms of low testosterone and declining growth hormone, so this isn't something patients can sort out on their own," said Dr

It is not approved for medical uses outside of Russia